Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Respiratory Disease: later-stage trial registry
3 of 8 indexed Respiratory Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Respiratory Disease: 8 US clinical trials tracked, 3 recruiting.
Respiratory Disease is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Restech Srl, running 1 of these trials.
Enrollment posture brief
Registry condition respiratory-disease
OPEN 3 | RECR 38% | LATE 1 | EARLY 0 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)
Respiratory Disease lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Respiratory Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Respiratory Disease is recruiting below its size-band peers.
3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Respiratory Disease trials is spread across many organizations.
Restech Srl accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Respiratory Disease enrolment sits around 218 participants.
Median target enrolment is 218 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.
-
Respiratory Disease research is mostly interventional.
6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
University of Maryland, Baltimore
NCT06002685
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
University of Florida
NCT06000761
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Geisinger Clinic
NCT06495021
Prematurity and Respiratory Outcomes Program (PROP)
University of Pennsylvania
NCT01435187
Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies
Restech Srl
NCT04006964
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
Icahn School of Medicine at Mount Sinai
NCT04619680
Clinical Use Cases Assessment of the Gabi System in Young Children With Underlying Medical Conditions (BRIDGE Study)
Gabi SmartCare
NCT05319236
Engineering Evaluation of the Helix Ventilator
Philips Respironics
NCT03613363
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Respiratory Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Respiratory Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Respiratory Disease page
8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Respiratory Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Restech Srl sponsors the most Respiratory Disease trials on record, review their full trial history before evaluating a specific study. See Restech Srl's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Respiratory Disease condition card totals 8 registered trials; most-linked intervention Helix Ventilator; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.